The New Rules of Drug Pricing, Access, and Value

April 29, 2021 11:00 AM - 12:00 PM

Webinar, click "live-stream" button to view

Add to Calendar 4/29/2021 11:00:00 AM 4/29/2021 12:00:00 PM The New Rules of Drug Pricing, Access, and Value

While the biopharma industry’s response to COVID-19 – creating and launching multiple breakthrough innovations in record time – has generated enormous confidence and respect for biopharma, it has also reinvigorated the drug pricing debate. Now, more than ever, it’s essential for companies to have a strategic and robust approach to pricing.

In this virtual Forum, Laurie Halloran (President & CEO of Halloran Consulting Group), Laura Randa (Chief Executive Officer, Randa BioPharma Solutions), Jennifer Petrillo Billet (Director, Sage Therapeutics) and Alex Santini (Senior Vice President of Market Access, Nektar Therapeutics)  will share their guidance and expertise on developing and implementing drug pricing, value, and access strategies. Topics will include: 

  • The importance of planning, with a focus on late-stage clinical trials
  • Best practices for working with payors
  • Market access and reimbursement – at home and abroad


Webinar link will be emailed to participants the day before - you can also access it from the "Live Stream" tab below. This event is for members-only.


NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Webinar, click "live-stream" button to view
President & CEO, Halloran Consulting Group
Laurie Halloran founded Halloran Consulting Group in 1998, originally operating out of an unfinished bathroom. Her time as a pediatric ICU nurse had inspired her to start a company that helps move new therapies through FDA processes to get them into the hands of patients desperately in need. By providing a strategic development team, innovative start-up companies could have access to world-class expertise at a fraction of the cost. Since its humble beginnings, Halloran has grown into a successful consultancy of like-minded experts who are dedicated to improving human health by making life science companies better at what they do. Laurie has been named 2018 Women’s Business Enterprise Star by the Women's Business Enterprise National Council (WBENC) and has won a 2017 Enterprising Women of the Year Award from Enterprising Women Magazine. Halloran Consulting Group was also named an Inc. 5000 Fastest Growing Company for the past three years in a row. In 2015, Laurie was honored by the Boston Business Journal as a Woman of Influence, in 2010 was selected as one of the 100 Most Inspiring People in Life Science by PharmaVoice, and in 2009, she was awarded Clinical Researcher of the Year by the New England Chapter of the Associate of Clinical Research Professionals. Laurie lectures at Boston University Medical School and the Tufts Center for Drug Development Post-Graduate program. She has previously taught at George Washington University and Harvard University. Laurie earned a Bachelor of Science in nursing from Russell Sage College and a Master of Science in management from Lesley University. She is also a Prosci Certified Change Practitioner.